Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Horng H. Chen, M.D., is a board-certified adult heart failure cardiologist and a physician-scientist with 20 years' experience in translational research, bridging the laboratory to the bedside. Dr. Chen is currently the principal investigator on three National Heart, Lung, and Blood Institute (NHLBI) research grants and a co-investigator on the NHLBI Heart Failure Clinical Research Network. His research focuses on cardiorenal dysfunction and heart failure together with novel natriuretic peptide therapeutics in the syndrome of heart failure.
Dr. Chen's research program has significant impact on clinical practice. The results of the Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE-AHF) study demonstrated that the routine use of low-dose dopamine or nesiritide in patients with acute heart failure and renal dysfunction was not useful to promote decongestion and preserve renal function. These findings have significantly changed the management of patients with acute heart failure. Dr. Chen's program continues to discover and translate novel therapeutics for heart failure.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.